4Hydroxyapatite Prostheses and Osseointegration
The bioactive ceramic that integrates with bone and resists extrusion, balanced against its brittleness and handling demands.
FA prosthesis made of bone mineral
Of all the synthetic materials a surgeon can place to rebuild the ossicular chain, hydroxyapatite is the one that most nearly is bone. It is a calcium-phosphate ceramicwhose composition and crystalline structure closely mimic the mineral phase of the human skeleton — the same hard matrix that the natural ossicles are built from. That single fact explains almost everything that follows: its remarkable tolerance in the middle ear, its ability to be set directly against the eardrum, its resistance to being pushed back out, and, unavoidably, its brittleness. This module is the story of that trade-off — a material that the body welcomes as kin, but which the surgeon must handle like glass.
Hydroxyapatite arrived in otology in the early 1980s through the work of Grote, who reasoned that a material chemically akin to bone ought to be tolerated where inert metals and polymers had often been rejected. He was right. In his long follow-up of patients reconstructed with dense hydroxyapatite assemblies set on the stapes head and malleus handle, the air-bone gap closed to within 20 dB in more than four-fifths of cases, with a durable hearing gain and — strikingly — no extrusions [1987]. For the first time a synthetic head could sit against the undersurface of the drum without the obligatory cartilage buffer that older materials demanded. The bioactive ceramic had earned its place in the middle ear.
FBioactive, not just biocompatible: how it integrates
It is worth being precise about why hydroxyapatite behaves so well, because the explanation also marks the boundary between this material and its rivals. Most implant materials are bioinert: the body tolerates them but does not embrace them, walling them off in a thin fibrous capsule. The implant sits in the tissue without bonding to it, held in place only by its mechanical seating. Polished titanium and the older polymers behave essentially this way. Hydroxyapatite is different. It is bioactive, or surface-active: its calcium-phosphate surface is chemically recognised by the host, and living bone is laid downdirectly onto it with no intervening fibrous layer. The implant and the host become continuous. This is osseointegration, and it is a true chemical bond, not a mechanical grip.
The distinction was formalised in the foundational materials-science work of Hench and Wilson, who divided endosseous implants into bonding and non-bonding classes and showed that surface-active calcium phosphates and bioactive glasses bond to bone through a hydroxyapatite-like surface layer, whereas inert metals are merely encapsulated [1984]. That this happens in real patients, not just in the laboratory, was confirmed when hydroxyapatite prostheses retrieved from human ears were examined histologically: they showed the same integration and epithelial coverage seen in animal models — living proof that the ceramic genuinely bonds to the middle-ear bony surfaces it touches [1990]. The widget below contrasts the two interface biologies side by side.
There is, however, a crucial caveat buried in that same histology. The retrieved-implant study found that while integration in a quiet ear matched the animal experiments, the reactions seen during chronic infection in the human middle ear were considerably more severe than in induced acute infection in animals[1990]. Osseointegration is real, but it is conditional: it depends on a dry, healthy, well-aerated host bed. Place the same bioactive ceramic in a wet, infected, poorly ventilated ear and the welcome cools. That conditionality is the thread that runs through every later decision in this module.
TExtrusion resistance and what the long-term series show
The headline clinical virtue of hydroxyapatite is its resistance to extrusion— the slow, relentless process by which a rigid foreign body works its way out through the eardrum. Because the ceramic integrates with the host rather than being walled off and pushed laterally, and because it provokes minimal inflammation, it can be placed against the drum with a much lower extrusion risk than the porous polyethylene prostheses it replaced. This is why Grote saw no extrusions in his original series and why hydroxyapatite was, for a time, marketed as the material that did not need a cartilage cap [1987].
The longer-term reality is more nuanced, and trainees should know both halves of it. Goldenberg’s four-year experience of 215 implants found a low extrusion rate of 4.3%for the hybrid form of the prosthesis, but also discovered that the solid ceramic was awkward to shape intraoperatively — the finding that drove the whole field toward hybrid designs [1992]. And in the longest follow-up, Shinohara and colleagues tracked 106 ears beyond five years: extrusion did occur, in 16%of ears at a mean of nearly 28 months, and the hearing success rate drifted down from 59% at one year to 50% by five years — far better for short columellas onto the stapes head (60%) than for long columellas onto the footplate (34%) [2000]. The lesson is that hydroxyapatite resists extrusion well, but not perfectly, and that late drift — not the early result — is the honest figure to quote a patient.
Two practical responses follow. First, in any compromised, atelectatic or revision ear, a thin cartilage cap is still placed between the ceramic head and the drum: even for hydroxyapatite this reduces extrusion, falling from 13.2% without cartilage to 1.9% with it in one direct comparison, and with no loss of hearing gain [2002]. Second, because the late deterioration clusters in poor ears, the decisive variable is the middle-ear environment, not the material in your hand — the same prognostic message that underlies modern ossiculoplasty staging [2001].
TBrittleness and the handling rules it forces
Everything that makes hydroxyapatite biologically excellent also makes it mechanically unforgiving. A ceramic that resembles bone mineral shares bone’s brittleness: it is hard and stiff but has almost no ductility, so it does not bend or yield under load — it simply fractures. This is the single most important thing to internalise before picking one up. Solid hydroxyapatite cannot be trimmed with scissors or a blade, cannot be crimped onto the stapes the way a malleable wire piston can, and cannot be levered to adjust its angle once seated. Each of those manoeuvres concentrates a shear or bending force that shatters or chips the ceramic. It was precisely this awkwardness in shaping that Goldenberg documented and that motivated hybrid designs [1992].
The correct way to size a hydroxyapatite prosthesis is by gentle diamond-burr abrasion under continuous irrigation— removing material gradually, without shock loading, while the irrigation carries away the heat that could otherwise crack the head. Placement against the drum is acceptable in a healthy ear, but every other instinct borrowed from working with ductile titanium has to be unlearned. The widget below walks through the common intraoperative manoeuvres and flags which are safe for the ceramic and which will break it.
A second consequence of brittleness is its behaviour in revision surgery. A hydroxyapatite prosthesis that has osseointegrated is genuinely anchored, which is a virtue while it works but a nuisance if it must be removed: it cannot simply be lifted out, and attempts to free it can fracture both the ceramic and the delicate ossicular remnant it has bonded to. The same bond that gives durability raises the cost of revision, a trade-off worth weighing when the ear is one likely to need further surgery.
CHybrids, and how hydroxyapatite measures up to titanium
The elegant solution to brittleness is to put the ceramic only where its biology is needed and a tougher material everywhere else. Hybrid prostheses do exactly this: a hydroxyapatite head provides the biocompatible, integrating, drum-friendly interface, while a shaft of a flexible polymer or a malleable metal supplies the strength, trimmability and adjustability that solid ceramic lacks. This dual-material design emerged directly from the early finding that monolithic hydroxyapatite was hard to handle, and the hybrids delivered the low extrusion rates of the ceramic with far better surgical maneuverability[1992]. For most contemporary uses, when a surgeon reaches for “a hydroxyapatite prosthesis” they mean a hybrid: a ceramic head on a workable shaft.
How does it compare with the modern workhorse, titanium? The honest answer, from the best head-to-head data, is: about the same. In a direct comparison of 168 ears reconstructed with hydroxyapatite versus titanium PORPs and TORPs, both materials gave good functional results with low extrusion and no statistically significant differencein hearing — with only non-significant trends favouring hydroxyapatite in total reconstructions and titanium in partial ones [2007]. The chart below shows those proportions achieving a closed air-bone gap.
Where the two materials genuinely differ is in handling and visualisation, not hearing. Titanium can be milled into open or fenestrated heads that let the surgeon see the shaft seat on the stapes, it is lighter, and it tolerates trimming and gentle crimping; hydroxyapatite is opaque, brittle and shaped only by abrasion. So the choice between them is rarely about audiometric outcome — it is about which the surgeon handles better, what the ear demands, and what is to hand. The numbers say the patient will hear much the same either way.
CChoosing hydroxyapatite: where it earns its place
Pulling the threads together gives a clear decision logic. Hydroxyapatite is at its best in the favourable ear: dry, well-aerated, healthy mucosa, no active infection, a good ossicular remnant to couple to. There its bioactive surface integrates, it sits happily against the drum, and its extrusion resistance is fully realised. Its long-track-record biocompatibility and its radiopacity — which lets you confirm position on later imaging — are genuine advantages. In that setting it is a sound, evidence-backed choice that will match titanium for hearing [2007].
Three cautions temper that enthusiasm. First, respect the brittleness: plan to shape it by burr, choose a hybrid when you need a trimmable or adjustable shaft, and never cut, crimp or lever solid ceramic. Second, protect the interface in the imperfect ear: in any atelectatic, revision or marginal ear, add a thin cartilage cap, because extrusion still happens and the cap nearly abolishes it without costing hearing[2002]. Third, counsel honestly on the long term: quote the five-year, not the one-year, figures, remember that results drift down in poor ears and that a short stapes-head columella outperforms a long footplate columella [2000]. Above all, keep the material decision in proportion: the dominant determinant of success is the middle-ear environment and the quality of coupling, and only after those are optimised does the choice between an integrating ceramic and a workable metal come into play [2001].
Which statement best guides your choice and handling of a hydroxyapatite prosthesis here?
Hydroxyapatite used for ossicular prostheses is best described chemically as which of the following?
What does it mean that hydroxyapatite is a 'bioactive' rather than a 'bioinert' implant material?
What is the principal practical disadvantage of solid hydroxyapatite compared with titanium during ossiculoplasty?
A trainee asks whether choosing hydroxyapatite over titanium will materially change the hearing result. Based on comparative evidence (Truy and colleagues) and prognostic staging (Dornhoffer and Gardner), what is the best answer?